PCSS MAT Half and Half Training 2021-2022-16693-Medical Considerations for Patients with Opioid Use Disorder

Video Transcription

Video Summary

In this video, Dr. Jeanette Tetreault presents a module on medical considerations for patients with opioid use disorder. She highlights the importance of training healthcare professionals in evidence-based practices for the prevention and treatment of opioid use disorders. Dr. Tetreault discusses the various infectious complications associated with injection drug use, including skin and soft tissue infections, injection drug use-related infective endocarditis, hepatitis C, and HIV. She emphasizes the need for healthcare professionals to consider these complications as opportunities to engage individuals in addiction treatment and implement harm reduction strategies. Dr. Tetreault also discusses the importance of screening patients for HIV and hepatitis C and offering treatment options such as opioid agonist therapy and antiviral medications. She emphasizes the role of addiction treatment and behavioral risk reduction counseling as prevention strategies for HIV and hepatitis C. Dr. Tetreault concludes by providing resources for further information and support, including the PCSS (Provider Clinical Support System) program, which offers educational resources and a mentorship program for healthcare professionals.

Keywords

opioid use disorder

infectious complications

injection drug use

addiction treatment

HIV

hepatitis C

opioid agonist therapy

PCSS program